Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-08 Sale |
2024-11-12 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
15,198 | $515 | $7,826,970 | 75,772 (Direct) |
View |
| 2024-07-30 Sale |
2024-08-01 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
15,202 | $505 | $7,677,010 | 90,970 (Direct) |
View |
| 2024-07-22 Sale |
2024-07-24 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
15,202 | $497 | $7,555,394 | 106,172 (Direct) |
View |
| 2024-05-24 Sale |
2024-05-29 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
1,565 | $457 | $715,205 | 121,374 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
15,202 | $447 | $6,795,294 | 121,374 (Direct) |
View |
| 2023-12-15 Sale |
2023-12-19 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
17,135 | $407 | $6,973,945 | 110,276 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-15 4:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
5,098 | $397 | $2,023,906 | 108,711 (Direct) |
View |
| 2023-11-13 Sale |
2023-11-15 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
5,097 | $377 | $1,921,569 | 113,809 (Direct) |
View |
| 2023-07-17 Sale |
2023-07-18 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
7,828 | $355 | $2,778,940 | 118,906 (Direct) |
View |
| 2023-04-27 Sale |
2023-05-01 4:26 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
3,317 | $339.08 | $1,124,726 | 126,652 (Direct) |
View |
| 2023-01-25 Sale |
2023-01-27 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
10,000 | $315.05 | $3,150,500 | 89,598 (Direct) |
View |
| 2022-08-15 Sale |
2022-08-17 5:40 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
11,689 | $305.06 | $3,565,846 | 99,598 (Direct) |
View |
| 2022-06-24 Sale |
2022-06-28 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
11,689 | $291.3 | $3,405,006 | 111,153 (Direct) |
View |
| 2021-08-19 Purchase |
2021-08-23 08:30 am |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
10,000 | $195.65 | $1,956,492 | 73,754 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-26 Tax Withholding |
2025-02-28 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
14,079 | $479.61 | 105,915 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,386 | $483.28 | 119,994 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:31 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
6,553 | $463.46 | 129,380 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
19,015 | $0 | 135,933 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
8,300 | $467.98 | 116,918 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
49,446 | $0 | 125,218 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-14 4:24 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director |
105,263 | $0 | 186,002 (Direct) |
View |
| 2024-05-24 Exercise |
2024-05-29 4:08 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
1,565 | $0 | 121,374 (Direct) |
View |
| 2024-05-24 Exercise |
2024-05-29 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
1,565 | $187.53 | 121,374 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:55 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,386 | $431.79 | 136,507 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,359 | $424.01 | 145,893 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
7,019 | $420.58 | 145,893 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
8,255 | $422.74 | 162,271 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
61,815 | $0 | 170,526 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
3,058 | $155.57 | 110,276 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:15 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
17,135 | $0 | 110,276 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
14,077 | $187.53 | 110,276 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:07 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director |
245,123 | $0 | 245,123 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,386 | $289.12 | 129,969 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:35 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,359 | $292.85 | 139,355 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 4:58 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
5,990 | $298.26 | 148,714 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 4:58 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
3,372 | $294.33 | 148,714 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
68,478 | $0 | 158,076 (Direct) |
View |
| 2022-09-30 Exercise |
2022-11-10 5:30 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director |
9,818 | $0 | 80,739 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 9:12 pm |
N/A 2032-06-10 |
Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director |
179,437 | $0 | 179,437 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 5:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
7,246 | $227.86 | 122,842 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 4:56 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
8,584 | $232.51 | 130,088 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:16 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
3,031 | $237.74 | 138,672 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
67,949 | $0 | 141,703 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 5:00 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director |
9,818 | $0 | 9,818 (Direct) |
View |
| 2021-09-16 Option Award |
2021-09-20 9:51 pm |
N/A 2031-09-15 |
Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director |
69,431 | $0 | 69,431 (Direct) |
View |